Ledger.Open graph →
SEC Form D · filed April 13, 2021

Entrada Therapeutics, Inc

Offering
$116.2M
Sold
$116.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Carole F. Nuechterlein · Boston, MADirectorNatarajan F. Sethuraman · Boston, MAExecKush M. Parmar · Boston, MADirectorTodd F. Foley · Boston, MADirectorPeter F. Kim · Boston, MADirectorNerissa F. Kreher · Boston, MAExecKory F. Wentworth · Boston, MAExecDipal Doshi · Boston, MAExec · DirectorJohn F. Crowley · Boston, MADirectorNathan F. Dowden · Boston, MAExecCarole F. Nuechterlein · Boston, MADirectorNatarajan F. Sethuraman · Boston, MAExecKush M. Parmar · Boston, MADirectorTodd F. Foley · Boston, MADirectorPeter F. Kim · Boston, MADirectorNerissa F. Kreher · Boston, MAExecKory F. Wentworth · Boston, MAExecDipal Doshi · Boston, MAExec · DirectorJohn F. Crowley · Boston, MADirectorNathan F. Dowden · Boston, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗